142 related articles for article (PubMed ID: 7743500)
1. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation.
Carson EB; McMahon M; Baylin SB; Nelkin BD
Cancer Res; 1995 May; 55(10):2048-52. PubMed ID: 7743500
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Höppener JW
Cancer Res; 2008 Mar; 68(5):1329-37. PubMed ID: 18316595
[TBL] [Abstract][Full Text] [Related]
3. Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.
Ameur N; Lacroix L; Roucan S; Roux V; Broutin S; Talbot M; Dupuy C; Caillou B; Schlumberger M; Bidart JM
Endocr Relat Cancer; 2009 Dec; 16(4):1261-72. PubMed ID: 19675075
[TBL] [Abstract][Full Text] [Related]
4. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT.
Bläker M; Arrenberg P; Stange I; Schulz M; Burghardt S; Michaelis H; Pace A; Greten H; von Schrenck T; de Weerth A
Regul Pept; 2004 Apr; 118(1-2):111-7. PubMed ID: 14759564
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells.
Carson-Walter EB; Smith DP; Ponder BA; Baylin SB; Nelkin BD
Oncogene; 1998 Jul; 17(3):367-76. PubMed ID: 9690518
[TBL] [Abstract][Full Text] [Related]
6. The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells.
Akeno-Stuart N; Croyle M; Knauf JA; Malaguarnera R; Vitagliano D; Santoro M; Stephan C; Grosios K; Wartmann M; Cozens R; Caravatti G; Fabbro D; Lane HA; Fagin JA
Cancer Res; 2007 Jul; 67(14):6956-64. PubMed ID: 17638907
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X
Hum Pathol; 2008 Jul; 39(7):994-1001. PubMed ID: 18508109
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
Cerrato A; De Falco V; Santoro M
J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
10. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
Marsh DJ; Andrew SD; Eng C; Learoyd DL; Capes AG; Pojer R; Richardson AL; Houghton C; Mulligan LM; Ponder BA; Robinson BG
Cancer Res; 1996 Mar; 56(6):1241-3. PubMed ID: 8640806
[TBL] [Abstract][Full Text] [Related]
11. Expression of v-Ha-ras driven by the calcitonin/calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma.
Johnston D; Hatzis D; Sunday ME
Oncogene; 1998 Jan; 16(2):167-77. PubMed ID: 9464534
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
13. Thyroid carcinomas with mixed follicular and C-cell differentiation patterns.
Papotti M; Volante M; Komminoth P; Sobrinho-Simões M; Bussolati G
Semin Diagn Pathol; 2000 May; 17(2):109-19. PubMed ID: 10839611
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma.
Rapa I; Saggiorato E; Giachino D; Palestini N; Orlandi F; Papotti M; Volante M
J Clin Endocrinol Metab; 2011 Jul; 96(7):2146-53. PubMed ID: 21543427
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
Chen H; Carson-Walter EB; Baylin SB; Nelkin BD; Ball DW
Surgery; 1996 Aug; 120(2):168-72; discussion 173. PubMed ID: 8751579
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
[TBL] [Abstract][Full Text] [Related]
17. The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.
Kushchayeva Y; Jensen K; Recupero A; Costello J; Patel A; Klubo-Gwiezdzinska J; Boyle L; Burman K; Vasko V
J Clin Endocrinol Metab; 2014 May; 99(5):E734-45. PubMed ID: 24483157
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and posttranscriptional modulation of calcitonin gene expression by sodium n-butyrate in cultured human medullary thyroid carcinoma.
Nakagawa T; Nelkin BD; Baylin SB; de Bustros A
Cancer Res; 1988 Apr; 48(8):2096-100. PubMed ID: 3258183
[TBL] [Abstract][Full Text] [Related]
19. Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer.
Barollo S; Pezzani R; Cristiani A; Bertazza L; Rubin B; Bulfone A; Pelizzo MR; Torresan F; Mantero F; Pennelli G; Moro S; Mian C
Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):546-50. PubMed ID: 23934677
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin receptor mRNA is expressed in human medullary thyroid carcinoma.
Frendo JL; Delage-Mourroux R; Cohen R; Pichaud F; Pidoux E; Guliana JM; Jullienne A
Thyroid; 1998 Feb; 8(2):141-7. PubMed ID: 9510122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]